Rohto Pharmaceutical Co.,Ltd.
4527
Rang in aandelen
#3847
Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global... Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global entity engaged in the development, manufacturing, and marketing of a diverse array of pharmaceutical goods, beauty products, and nutritional supplements. Their comprehensive product line includes various ophthalmic solutions such as eye drops, contact lens care products, and eye washes. For skincare, they offer facial treatments like cleansers, toners, and creams, in addition to specialized medicated preparations for the skin. The company's offerings also extend to internal medicines, encompassing digestive aids, herbal remedies, and dietary supplements. Furthermore, they supply over-the-counter medications and deliver beauty and health services via dedicated counters. The company rebranded from Yamada Pharmaceutical to Rohto Pharmaceutical Co.,Ltd. in September 1949.
Aandeelprijs
$19.13
Marktkapitalisatie
$4.32B
Verandering (1 dag)
0.65%
Verandering (1 jaar)
16.92%
Land
JP
Handel Rohto Pharmaceutical Co.,Ltd. (4527)
Categorie
Consumer Defensive
Winst voor Rohto Pharmaceutical Co.,Ltd. (4527)
Winst in Jun 2026 TTM: $303.71M
Volgens de meest recente financiële verslagen van Rohto Pharmaceutical Co.,Ltd. bedraagt de huidige winst van het bedrijf $303.71M. In 2024 behaalde het bedrijf een winst van $274.31M, een stijging ten opzichte van de winst van 2023, die $258.26M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Rohto Pharmaceutical Co.,Ltd. van 2008 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $303.71M | 7.55% |
| 2025 | $282.40M | 2.95% |
| 2024 | $274.31M | 6.21% |
| 2023 | $258.26M | 12.49% |
| 2022 | $229.58M | 10.53% |
| 2021 | $207.71M | 2.77% |
| 2020 | $202.12M | 37.64% |
| 2019 | $146.85M | -7.24% |
| 2018 | $158.31M | 19.53% |
| 2017 | $132.44M | 4.19% |
| 2016 | $127.12M | 10.88% |
| 2015 | $114.65M | -19.00% |
| 2014 | $141.54M | -2.14% |
| 2013 | $144.64M | -14.82% |
| 2012 | $169.81M | 4.81% |
| 2011 | $162.02M | 21.98% |
| 2010 | $132.83M | 41.40% |
| 2009 | $93.94M | -24.26% |
| 2008 | $124.03M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $20.38B | 6,609.37% |
US
|
|
| $9.83B | 3,135.44% |
FR
|
|
| $2.94B | 868.36% |
US
|
|
| $1.55B | 410.35% |
IN
|
|
| $517.00M | 70.23% |
US
|
